Corporate
Description
  • Value proposition

    Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.

    Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il

    Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here:
    http://www.tevapharm.com/contact_us/

    generic medicines, specialty medicines, CNS, active pharmaceutical ingredients, respiratory, biosimilars, biologics, pain care, migraine, and oncology

Entity interactions BETA
Entity TypeTweets Articles
Movember Movember
entertainment, Non-profit Organizations
Other

3 Mar 2022


Keysight Technologies Keysight Technologies
Appliances, Electrical, and Electronics Manufacturing
Other

16 Oct 2019


Warwick in Africa Warwick in Africa
edtech, Primary and Secondary Education
Other

19 May 2022


Golden Valley Golden Valley
Architecture and Planning
Other

12 Feb 2022


High Impact Technology Exchange Conference (HI-TEC) High Impact Technology Exchange Conference (HI-TEC)
Higher Education, edtech
Other

25 Jul 2018


Institution of Engineering Designers Institution of Engineering Designers
edtech, Design Services
Other

12 Jul 2012


Qwince Qwince
it services, IT Services and IT Consulting
Other

23 Sep 2016


inside-it.ch inside-it.ch
Online Media, media
Not capitalistic
Partnership
Not event

19 Jul 2022


Radars
Loading...